CRISPR Therapeutics logo

CRISPR Therapeutics

Gene-based medicines for patients with serious diseases

350 employees · est. 2013 · Boston, United States

VS
Ligandal logo

Ligandal

Ligandal is developing precision molecular therapeutics and targeted delivery technologies.

12 employees · est. 2014 · San Francisco, United States

CRISPR Therapeutics is the older company (2013 vs 2014); CRISPR Therapeutics is the larger of the two.

Side-by-Side Comparison

CRISPR Therapeutics Ligandal
Founded
2013 older 2014
Headquarters
Boston, United States San Francisco, United States
Employees
350 larger 12
Industry
Biopharma, Biotechnology Biotechnology
Funding Stage
IPO Seed
Total Funding
$1.05B $2.13M
Funding Rounds
7 3
Services
Development of gene-based medicines, Gene-editing therapies, Clinical and preclinical research, Patient advocacy Not tracked yet
Target Customers
Patients with serious diseases, Healthcare providers, Biotechnology companies, Research institutions Not tracked yet
Taxonomy
Gene-based Medicines, CRISPR Technology, Gene Editing, Hematology, Oncology, Regenerative Medicine, Cardiovascular Diseases, Autoimmune Diseases, Rare Diseases, Transfusion-Dependent Beta Thalassemia, Sickle Cell Disease, Biopharmaceuticals, CRISPR/Cas9 Platform, Strategic Partnerships, Nobel Prize-winning Innovations Precision Medicine, Genetic Medicine, Nanotechnology, Therapeutics, Vaccines, Immuno-oncology, Rare Genetic Diseases, Peptide-based Cure, COVID-19, Nanomedicine, Gene Therapies, Targeted Delivery Technologies, Regenerative Medicine, CRISPR
Website
crisprtx.com ligandal.com
CRISPR Therapeutics logo

About CRISPR Therapeutics

CRISPR Therapeutics, a leader in biopharma and biotechnology, stands at the forefront of creating gene-based medicines for patients with serious diseases. Since its founding in 2013, the company has not only evolved but thrived by leveraging CRISPR technology, a Nobel Prize-winning innovation that h...

Ligandal logo

About Ligandal

Ligandal is a biotechnology startup founded in 2014 and based in the United States. The company's slogan, "Ligandal is developing precision molecular therapeutics and targeted delivery technologies." reflects its core focus on genetic medicine and nanotechnology to develop personalized therapies. Li...

We will tell you when either one moves

BounceWatch watches CRISPR Therapeutics and Ligandal for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CRISPR Therapeutics and Ligandal — by email.

Frequently Asked Questions

CRISPR Therapeutics — Gene-based medicines for patients with serious diseases. Ligandal — Ligandal is developing precision molecular therapeutics and targeted delivery technologies.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CRISPR Therapeutics has raised $1.05B while Ligandal has raised $2.13M.
CRISPR Therapeutics and Ligandal operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CRISPR Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CRISPR Therapeutics on 3 Jul 2026, and Ligandal on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy